Quick Answer
Rice Protein Resistance Training Meta-Analysis has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Such muscle attenuations can further contribute to strength deterioration and physical mobility decline, which in turn result in high risks of frailty and disability in the elderly [,,].
Key Takeaways
- 01Such muscle attenuations can further contribute to strength deterioration and physical mobility decline, which in turn result in high risks of frailty and disability in the elderly [,,]. [Lin Che-Li (2026)]
- 0212 13 14 15 16 17 18 19 20 The main factor behind the development and progression of sarcopenia is thought to be a reduced muscle protein synthesis response (i.e., myogenesis) and a negative muscle balance in older adults [,]. [Lin Che-Li (2026)]
- 03As a result, numerous authors have emphasized the need for a comprehensive tool that could assist with the diagnosis or the assessment of sarcopenia risk factors [,,]. [Lin Che-Li (2026)]
- 041 2 3 4 5 6 7 8 9 10 11 Sarcopenia has been recognized as a skeletal muscle disease commonly derived from aging-induced muscle degeneration, including the loss of muscle mass and morphological changes [,]. [Lin Che-Li (2026)]
The current Migaku evidence database contains 1 reusable source document for Rice Protein Resistance Training Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts.
- Such muscle attenuations can further contribute to strength deterioration and physical mobility decline, which in turn result in high risks of frailty and disability in the elderly [,,]. [Lin Che-Li (2026); evidence level 1]
- 12 13 14 15 16 17 18 19 20 The main factor behind the development and progression of sarcopenia is thought to be a reduced muscle protein synthesis response (i.e., myogenesis) and a negative muscle balance in older adults [,]. [Lin Che-Li (2026); evidence level 1]
- As a result, numerous authors have emphasized the need for a comprehensive tool that could assist with the diagnosis or the assessment of sarcopenia risk factors [,,]. [Lin Che-Li (2026); evidence level 1]
- 1 2 3 4 5 6 7 8 9 10 11 Sarcopenia has been recognized as a skeletal muscle disease commonly derived from aging-induced muscle degeneration, including the loss of muscle mass and morphological changes [,]. [Lin Che-Li (2026); evidence level 1]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources